Elevance Health (ELV) Competitors

$539.18
+0.60 (+0.11%)
(As of 05/10/2024 ET)

ELV vs. CI, CNC, HUM, UNH, SNY, SYK, ISRG, MDT, BSX, and REGN

Should you be buying Elevance Health stock or one of its competitors? The main competitors of Elevance Health include The Cigna Group (CI), Centene (CNC), Humana (HUM), UnitedHealth Group (UNH), Sanofi (SNY), Stryker (SYK), Intuitive Surgical (ISRG), Medtronic (MDT), Boston Scientific (BSX), and Regeneron Pharmaceuticals (REGN). These companies are all part of the "medical" sector.

Elevance Health vs.

Elevance Health (NYSE:ELV) and The Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, community ranking, dividends, analyst recommendations, institutional ownership and valuation.

Elevance Health presently has a consensus price target of $587.42, suggesting a potential upside of 8.95%. The Cigna Group has a consensus price target of $366.14, suggesting a potential upside of 5.10%. Given Elevance Health's higher possible upside, equities analysts plainly believe Elevance Health is more favorable than The Cigna Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.92
The Cigna Group
0 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.92

The Cigna Group received 97 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 71.86% of users gave The Cigna Group an outperform vote while only 66.61% of users gave Elevance Health an outperform vote.

CompanyUnderperformOutperform
Elevance HealthOutperform Votes
830
66.61%
Underperform Votes
416
33.39%
The Cigna GroupOutperform Votes
927
71.86%
Underperform Votes
363
28.14%

Elevance Health has a net margin of 3.64% compared to The Cigna Group's net margin of 1.76%. Elevance Health's return on equity of 20.62% beat The Cigna Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health3.64% 20.62% 7.35%
The Cigna Group 1.76%17.24%5.09%

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 87.0% of The Cigna Group shares are held by institutional investors. 0.4% of Elevance Health shares are held by company insiders. Comparatively, 0.6% of The Cigna Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, The Cigna Group had 15 more articles in the media than Elevance Health. MarketBeat recorded 25 mentions for The Cigna Group and 10 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.16 beat The Cigna Group's score of 0.88 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
8 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
The Cigna Group
9 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. The Cigna Group pays an annual dividend of $5.60 per share and has a dividend yield of 1.6%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. The Cigna Group pays out 46.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Elevance Health has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, The Cigna Group has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500.

Elevance Health has higher earnings, but lower revenue than The Cigna Group. Elevance Health is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$171.34B0.73$5.99B$26.4620.38
The Cigna Group$195.27B0.51$5.16B$12.1828.60

Summary

Elevance Health beats The Cigna Group on 12 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELV vs. The Competition

MetricElevance HealthHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$125.32B$67.23B$5.09B$17.83B
Dividend Yield1.21%1.34%37.43%3.46%
P/E Ratio20.3816.99137.7023.15
Price / Sales0.730.552,421.7110.29
Price / Cash13.0610.4147.7718.08
Price / Book3.083.895.316.05
Net Income$5.99B$3.04B$106.18M$967.12M
7 Day Performance2.32%7.48%-0.88%1.48%
1 Month Performance7.41%10.68%-3.03%0.92%
1 Year Performance18.04%18.59%4.22%122.16%

Elevance Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CI
The Cigna Group
4.7032 of 5 stars
$346.70
+1.3%
$366.14
+5.6%
+32.2%$98.49B$195.27B28.4672,500Options Volume
CNC
Centene
4.5053 of 5 stars
$75.90
+1.0%
$85.23
+12.3%
+16.3%$40.50B$154.00B15.0967,700
HUM
Humana
4.9984 of 5 stars
$324.63
+1.7%
$424.50
+30.8%
-36.6%$39.12B$106.37B20.2167,600Analyst Revision
UNH
UnitedHealth Group
4.9809 of 5 stars
$500.96
+1.3%
$570.05
+13.8%
+4.7%$460.92B$371.62B30.62440,000
SNY
Sanofi
2.8647 of 5 stars
$49.57
+0.5%
$55.00
+11.0%
-9.7%$125.39B$46.61B24.9186,088Short Interest ↑
News Coverage
SYK
Stryker
4.9713 of 5 stars
$332.14
+2.0%
$365.94
+10.2%
+15.8%$126.53B$20.50B37.9252,000Dividend Announcement
ISRG
Intuitive Surgical
4.6154 of 5 stars
$388.65
+1.5%
$396.17
+1.9%
+27.8%$137.86B$7.12B70.1513,676Short Interest ↑
MDT
Medtronic
4.5787 of 5 stars
$81.88
+0.1%
$94.91
+15.9%
-7.3%$108.72B$31.23B26.0895,000
BSX
Boston Scientific
4.412 of 5 stars
$73.43
+1.2%
$75.09
+2.3%
+38.5%$107.73B$14.24B61.7148,000Insider Selling
Options Volume
REGN
Regeneron Pharmaceuticals
4.1023 of 5 stars
$969.97
+1.2%
$981.71
+1.2%
+29.9%$106.46B$13.12B28.6513,450Positive News

Related Companies and Tools

This page (NYSE:ELV) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners